Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 15.25
(-3.17%)
TWD 15.25
(-3.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 315.98 Million | 318.23 Million | 243.36 Million | 235.57 Million | 205.8 Million |
| Cost of Revenue | 117.52 Million | 125.65 Million | 118.57 Million | 108.02 Million | 94.23 Million |
| Gross Profit | 198.45 Million | 192.58 Million | 124.79 Million | 127.54 Million | 111.56 Million |
| Operating Expenses | 194.18 Million | 184.17 Million | 227.58 Million | 212 Million | 274.85 Million |
| Selling, General and Administrative Expenses | 177.46 Million | 168.03 Million | 182.07 Million | 172.67 Million | 199.23 Million |
| Research and Development Expenses | 16.72 Million | 16.14 Million | 45.5 Million | 39.33 Million | 67.29 Million |
| Other Expenses | 4.26 Million | 1.71 Million | -4.24 Million | 18.11 Million | - |
| Cost and Expenses | 315.98 Million | 309.83 Million | 346.15 Million | 320.03 Million | 369.09 Million |
| Operating Income | -2.25 Million | 10.6 Million | -106.91 Million | -66.2 Million | -154.97 Million |
| Interest Expense | 7.29 Million | 6.13 Million | 7.43 Million | 10.44 Million | 10.1 Million |
| Income Tax Expense | -705 Thousand | 515 Thousand | 4.08 Million | 3.26 Million | 1.49 Million |
| Earnings before Tax | -11.38 Million | 3.68 Million | -114.44 Million | -83.12 Million | -173.17 Million |
| Net Income | -10.68 Million | 3.17 Million | -118.52 Million | -86.39 Million | -174.66 Million |
| Earnings Per Share Basic | -0.12 | 0.04 | -1.32 | -1.07 | -2.30 |
| Earnings Per Share Diluted | -0.12 | 0.04 | -1.32 | -1.07 | -2.30 |
| Weighted Average Shares Outstanding | 90 Million | 90 Million | 90 Million | 81.04 Million | 75.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 90 Million | 90 Million | 90 Million | 81.04 Million | 75.79 Million |
| Gross Margin | 0.63 | 0.61 | 0.51 | 0.54 | 0.54 |
| EBIT Margin | 0.07 | 0.12 | -0.31 | -0.14 | -0.63 |
| Profit Margin | -0.03 | 0.01 | -0.49 | -0.37 | -0.85 |
| EBITDA | 21.81 Million | 38.79 Million | -76.68 Million | -39.17 Million | -128.36 Million |
| Earnings Before Tax Margin | -0.01 | 0.03 | -0.44 | -0.28 | -0.75 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 75.83 Million | 75.83 Million | 93.58 Million | 315.98 Million | 93.58 Million | 64.41 Million |
| Cost of Revenue | 27.31 Million | 27.31 Million | 27.51 Million | 117.52 Million | 27.51 Million | 31.24 Million |
| Gross Profit | 48.52 Million | 48.52 Million | 66.06 Million | 198.45 Million | 66.06 Million | 33.16 Million |
| Operating Expenses | 49.11 Million | 49.11 Million | 52.07 Million | 194.18 Million | 52.07 Million | 49.93 Million |
| Selling, General and Administrative Expenses | 46.04 Million | 46.04 Million | 45.35 Million | - | 45.35 Million | 44.29 Million |
| Research and Development Expenses | 4.38 Million | 4.38 Million | 5.79 Million | - | 5.79 Million | 4.22 Million |
| Other Expenses | - | - | - | -8.01 Million | - | - |
| Cost and Expenses | 76.42 Million | 76.42 Million | 79.59 Million | 311.71 Million | 79.59 Million | 81.18 Million |
| Operating Income | -1.9 Million | -1.9 Million | 16.57 Million | -2.25 Million | 16.57 Million | -15.36 Million |
| Interest Expense | - | - | - | 7.29 Million | - | - |
| Income Tax Expense | - | - | 352.5 Thousand | -705 Thousand | 352.5 Thousand | - |
| Earnings before Tax | -2.2 Million | -2.2 Million | 12.55 Million | -11.38 Million | 12.55 Million | -18.25 Million |
| Net Income | -2.2 Million | -2.2 Million | 12.9 Million | -10.68 Million | 12.9 Million | -18.25 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | 0.14 | - | 0.14 | -0.20 |
| Earnings Per Share Diluted | -0.02 | -0.02 | 0.14 | - | 0.14 | -0.20 |
| Weighted Average Shares Outstanding | 88.24 Million | 88.24 Million | 90 Million | 90 Million | 90 Million | 90 Million |
| Weighted Average Shares Outstanding (Diluted) | 88.24 Million | 88.24 Million | 90 Million | 90 Million | 90 Million | 90 Million |
| Gross Margin | 0.64 | 0.64 | 0.71 | 0.63 | 0.71 | 0.51 |
| EBIT Margin | 0.04 | 0.04 | 0.23 | - | 0.23 | -0.15 |
| Profit Margin | -0.03 | -0.03 | 0.14 | -0.03 | 0.14 | -0.28 |
| EBITDA | 3.24 Million | 3.24 Million | 21.39 Million | - | 21.39 Million | -9.83 Million |
| Earnings Before Tax Margin | -0.03 | -0.03 | 0.18 | -0.01 | 0.18 | -0.24 |
INVEST
009160
PBBK
FATBB
JMHLY
DHBK